Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 17.70M | 16.72M | 12.06M | 5.93M | 1.49M | 1.49M |
Gross Profit | 6.46M | 6.37M | 5.49M | 3.26M | 910.14K | 527.79K |
EBITDA | 2.41M | 2.06M | -13.50M | -24.59M | -16.59M | 16.25M |
Net Income | 1.30M | 1.23M | -14.15M | -28.59M | -19.43M | 19.92M |
Balance Sheet | ||||||
Total Assets | 15.04M | 10.22M | 11.78M | 24.18M | 37.33M | 42.65M |
Cash, Cash Equivalents and Short-Term Investments | 6.09M | 1.23M | 2.20M | 3.83M | 4.38M | 4.57M |
Total Debt | 2.41M | 2.41M | 6.84M | 6.60M | 4.28M | 2.23M |
Total Liabilities | 7.87M | 7.47M | 12.07M | 10.93M | 6.17M | 3.95M |
Stockholders Equity | 10.35M | 6.13M | 3.96M | 13.97M | 27.38M | 32.94M |
Cash Flow | ||||||
Free Cash Flow | -1.27M | -1.69M | -3.39M | -4.17M | -8.86M | -3.26M |
Operating Cash Flow | 65.00K | -503.33K | -3.18M | -3.61M | -8.57M | -3.26M |
Investing Cash Flow | -249.97K | -213.03K | 1.48M | -808.30K | -3.51M | -70.33K |
Financing Cash Flow | 4.66M | -181.11K | 95.35K | 3.87M | 11.90M | 7.75M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
67 Neutral | $17.04B | 11.60 | 9.79% | 3.95% | 10.64% | 1.80% | |
62 Neutral | C$37.36M | 26.43 | 18.68% | ― | 38.95% | ― | |
― | $1.48M | ― | ― | ― | ― | ||
― | $13.89M | ― | -105.94% | ― | ― | ― | |
― | $4.32M | ― | -337.09% | ― | ― | ― | |
― | $777.71K | ― | ― | ― | ― | ||
51 Neutral | C$9.71M | ― | -251.82% | ― | -4.88% | 93.73% |
Victory Square Technologies announced that the British Columbia Securities Commission has revoked the management cease trade order, which was initially issued due to a delay in filing their audited annual financial statements. The company has since filed both its annual and interim financial statements, bringing it up to date with its continuous disclosure obligations. This revocation allows management and insiders to resume trading in the company’s securities, potentially stabilizing investor confidence and enhancing the company’s operational transparency.
Victory Square Technologies reported its Q1 2025 financial results, highlighting a focus on expanding its holdings in the digital health and wellness sector. The company sees significant growth opportunities in this fragmented market, exemplified by its flagship holding, Hydreight Technologies, which offers a compliant platform for healthcare services across the U.S. Additionally, Victory Square holds stakes in Insu Therapeutics, which is developing an oral insulin tablet, and Pawsible Ventures, which is exploring pet wellness and telehealth opportunities. These strategic focuses aim to leverage Victory Square’s expertise in digital health to create scalable business opportunities.
Victory Square Technologies reported significant financial growth in 2024, with adjusted revenue reaching $23 million, up from $17.6 million in 2023. The company achieved strategic milestones, including the sale of BlockX and expansion in healthcare investments, positioning it for continued growth. Hydreight Technologies, a key portfolio company, expanded its digital health platform across the U.S., achieving national recognition and supporting a large network of healthcare professionals. Victory Square also advanced its digital health initiatives and invested in Insu Therapeutics, which is developing an innovative oral insulin tablet for diabetes care.
Victory Square Technologies Inc. announced a delay in filing its audited annual financial statements and management’s discussion and analysis for the fiscal year ended December 31, 2024, leading to a management cease trade order (MCTO) that restricts its CEO and CFO from trading company securities until the filings are completed. The company anticipates completing these filings by June 20, 2025, and has confirmed compliance with regulatory guidelines, with no undisclosed material changes or defaults.
Victory Square Technologies Inc. has announced a delay in filing its audited annual financial statements and related documents for the fiscal year ending December 31, 2024, resulting in a management cease trade order for its CEO and CFO. Despite the delay, Victory Square is working diligently to complete these filings by June 11, 2025, and has assured stakeholders that no material changes or undisclosed information have occurred since the default announcement.
Victory Square Technologies has announced a delay in filing its audited annual financial statements and related documents for the fiscal year ending December 31, 2024. The company has been granted a management cease trade order, restricting its CEO and CFO from trading in company securities until the filings are completed, expected by May 30, 2025. The delay does not affect other shareholders’ ability to trade. VST is working diligently to complete the filings and has confirmed no material changes or undisclosed information since the default announcement.